Sign in
4

Changes in Ownership

Natera, Inc. Filed Acc 0001415889-24-030182

PRESIDENT, CLINICALDIAGNOSTICS sold 2,428 shares at an average $159.60 ($387,511)

  • PRESIDENT, CLINICALDIAGNOSTICS acquired 4,719 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-20 Grant or award : show line 1 in the form 10b5-1 +1,675 116,381 D
2024-12-20 Grant or award : show line 2 in the form 10b5-1 +3,044 119,425 D
2024-12-23 Sale : show line 3 in the form 10b5-1 −2 $158.06 $316 119,423 D
2024-12-23 Sale : show line 4 in the form 10b5-1 −3 $158.19 $475 119,420 D
2024-12-23 Sale : show line 5 in the form 10b5-1 −2,423 $159.60 $386,721 116,997 D
Open-market sales · 2,428 sh · avg $159.60 · $387,511
Loading xslF345X05/form4-12262024_091201.xml…